Trials / Completed
CompletedNCT00603772
Clinical Evaluation of the Photoallergy Potential of Atralin Gel
Clinical Evaluation of the Photoallergy Potential of Atralin Gel (Tretinoin Gel 0.05%)
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Coria Laboratories, Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
To assess the potential of tretinoin gel 0.05% and its vehicle to produce photoallergic reactions, measured as skin reactions following induction and challenge.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Atralin (tretinoin) gel, 0.05% | Assess photoallergic reactions for tretinoin 0.05% and vehicle, measured as skin reactions following induction and challenge. |
Timeline
- Start date
- 2008-01-01
- Primary completion
- 2008-03-01
- Completion
- 2008-03-01
- First posted
- 2008-01-29
- Last updated
- 2008-05-06
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00603772. Inclusion in this directory is not an endorsement.